![](/img/cover-not-exists.png)
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts
P Munderi, AS Walker, C Kityo, AG Babiker, F Ssali, A Reid, JH Darbyshire, H Grosskurth, P Mugyenyi, DM Gibb, CF Gilks, on behalf of the DART/NORA trial teamsVolume:
11
Year:
2010
Language:
english
Pages:
11
DOI:
10.1111/j.1468-1293.2009.00786.x
File:
PDF, 272 KB
english, 2010